Has Martin McElya received payments from drug or device companies?

Yes. Drug and device makers reported $5,311 in general payments to Martin McElya across 247 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Martin McElya did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Martin McElya come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Martin McElya

Family Medicine · Dallas, TXNPI 1154329746

Payments from drug & device makers

$5,311in general payments, 2019–2025

Across 247 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$685
Supernus Pharmaceuticals, Inc.$541
Novo Nordisk$409
Genentech USA, Inc.$299
AbbVie$256
Amarin Pharma, Inc.$220
plus $3K from 47 others

What the payments were for

Speaking & faculty fees$5009%
Food & beverage$4,81191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	37	$685
Supernus Pharmaceuticals, Inc.	4	$541
Novo Nordisk	26	$409
Genentech USA, Inc.	18	$299
AbbVie(2 entities)	25	$256
Amarin Pharma, Inc.	10	$220
Lilly USA, LLC	12	$187
Organogenesis Inc.	4	$169
Amgen	4	$167
Smith+Nephew	7	$164
Bardy Diagnostics, Inc.	1	$159
AstraZeneca	10	$142
Sanofi-aventis U.S. LLC	5	$132
Paratek Pharmaceuticals, Inc.	7	$115
VBI Vaccine (delaware) Inc.	4	$112
MDD US Operations, LLC	1	$107
Exact Sciences	5	$107
Boehringer Ingelheim	3	$99
Idorsia Pharmaceuticals US Inc	5	$90
Abbott	3	$62
Nevro Corp.	1	$62
Stryker	1	$61
Medtronic	4	$61
Pfizer	3	$60
Verity Pharmaceuticals Inc.	2	$57
Indivior Inc.	3	$51
Orthofix Medical, Inc.	3	$50
Corium, LLC	2	$43
Ironshore Pharmaceuticals Inc.	3	$43
Astellas Pharma US Inc	2	$42
Tris Pharma Inc	2	$41
Althera Pharmaceuticals LLC	2	$36
Noven Therapeutics, LLC	2	$35
Convatec Inc.	1	$34
Adlon Therapeutics L.p.	2	$30
Hologic Sales And Service, LLC	1	$29
Scilex Pharmaceuticals Inc.	2	$28
Treace Medical Concepts, Inc.	1	$27
GSK	2	$27
Optinose US, Inc.	2	$26
Shire North American Group Inc	2	$26
Biohaven Pharmaceutical Holding Company Ltd.	1	$25
Dynavax Technologies Corporation	2	$22
Pacira Pharmaceuticals Incorporated	1	$22
Alk-abello, Inc	1	$21
KCI USA, Inc.	1	$20
Echosens North America, Inc.	1	$19
Seqirus USA Inc	1	$17
USWM, LLC	1	$17
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Impel Pharmaceuticals Inc.	1	$16
Si-bone, Inc.	1	$14
Topcon Healthcare Solutions, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,311 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	41	$1,874

Paid to pharmacies, not to this prescriber.

Other family medicine in Dallas

Thomas KingDallas$12M
Jennifer ZonDallas$5.9M
Chrisette DharmagunaratneDallas$5.6M
Michele ReynoldsDallas$3.8M
Shiwali RaiDallas$2.8M
Douglas DenhamSan Antonio$68.5M
Vicki MillerPasadena$58.3M
Hareshkumar BogharaDesoto$30.3M
Earl MartinTomball$30.1M
Lisa HollowayHouston$30.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →